1614
M. Ißsıklan et al. / Polyhedron 29 (2010) 1612–1618
2.2.6. 4,4,6,6-Tetramorpholino-3-tert-butyl-3,4-dihydrospiro[1,3,2-
benzoxazaphosphorine][2k5,4k5,6k5] [1,3,5,2,4,6]triazatriphosphorine
(1e)
2.2.10. 4,4,6,6-Tetrapyrrolidino-3-phenyl-3,4-dihydrospiro[1,3,2-
benzoxazaphosphorine][2k5,4k5,6k5] [1,3,5,2,4,6]triazatriphosphorine
(2c)
Morpholine (1.14 mL, 12.7 mmol) and triethylamine (10.0 mL)
The workup procedure was similar to that of compound 1c,
using pyrrolidine (7.00 mL, 84.6 mmol) and 2a (1.00 g, 2.11 mmol).
(THF/Toluene; 1:3, Rf = 0.44). Yield; 0.45 g (31%) and mp: 210 °C.
Anal. Calc. for C29H43N8P3O3; C, 56.89; H, 7.02; N, 18.29. Found:
C, 57.06; H, 6.91; N, 18.24%., m/z: 612 (613 [M + H]+). FTIR (KBr,
were added to
a stirred solution of compound 1a (1.00 g,
2.20 mmol) in dry toluene (100 mL) at room temperature. The mix-
ture was refluxed for 48 h, and the precipitated triethylaminehy-
drochloride was filtered off. The solvent was evaporated and the
product was purified by column chromatography with THF/Tolu-
ene (1:3). White powder was crystallized from acetonitrile. (THF,
Rf = 0.91). Yield; 0.47 g (30%) and mp: 219 °C. Anal. Calc. for
C27H47N8P3O5; C, 49.38; H, 7.21; N, 17.06. Found: C, 50.00; H,
cmꢀ1):
m 3087;3067 (C–H arom.), 2946;2860 (C–H aliph.),
1199;1172 (P@N). 1H NMR: (500 MHz, CDCl3, ppm): d 3.20 (m,
3
4H, NCH2 pyrr.), 3.79 (m, 4H, JHH = 7.5 Hz, NCH2CH2 pyrr.), 4.74
3
3
(m, 2H, JPH = 14. Hz, JHH = 7.5 Hz, H1), 7.15–7.44 (m, 4H, Ar–H).
6.71; N, 16.56%., m/z: 656 (657 [M + H]+). FTIR (KBr, cmꢀ1):
m
13C{1H} NMR: (125 MHz, CDCl3, ppm): d 44.16 (NCH2 pyrr.),
52.39 (d, JPC = 2.5 Hz, C1), 66.42 (d, JPC = 10.4 Hz NCH2CH2 pyrr.),
118.92 (d, JPC = 8.1 Hz, C4), 124.49 (C11), 125.24 (d, JPC = 5.7 Hz,
C6) 126.63 (C5), 126.66 (d, JPC = 7.2 Hz, C9), 126.71 (C7), 129.28
2
3
3094;3074 (C–H arom.), 2975;2847 (C–H aliph.), 1246;1180
(P@N). 1H NMR: (500 MHz, CDCl3, ppm): d 1.49 (s, 9H, CH3), 3.16
3
3
3
3
and 3.65 (m, 16H, NCH2CH2 morp.), 4.19 (d, 2H, JPH = 15.5 Hz,
H1), 6.84–7.20 (m, 4H, Ar–H). 13C{1H} NMR: (125 MHz, CDCl3,
(C4), 129.64 (C10), 142.08 (d, JPC = 2.6 Hz, C8), 150.62 (d,
2
ppm): d 29.46 (d, 3JPC = 3.3 Hz, CH3), 44.92 and 44.86 (NCH2 morp.),
2JPC = 8.3 Hz, C3).
2
2
45.03 (d, JPC = 2.4 Hz, C1), 55.85 (C(CH3)3), 67.50 (d, JPC = 4.3 Hz,
3
NCH2CH2 morp.), 117.61 (d, JPC = 5.8 Hz, C4), 123.27 (C6), 126.26
2.2.11. Microwave-assisted synthesis of compound 2c
Pyrrolidine (7.00 mL, 84.6 mmol) and triethylamine (10.0 mL)
were added to a stirred solution of compound 2a (1.00 g,
3
(C7), 128.60 (d, JPC = 6.4 Hz, C2), 129.26 (C5), 151.96 (d,
2JPC = 9.3 Hz, C3).
2.11 mmol) in dry toluene (100 mL). The mixture was refluxed
for 15 min and triethylaminehydrochloride was filtered off. Tolu-
ene was evaporated and the crude product was purified by column
chromatography with THF/Toluene (1:3), yield; 1.25 g (97%).
2.2.7. Microwave-assisted synthesis of 1e
Morpholine (1.14 mL, 12.72 mmol) and triethylamine
(10.00 mL) were added to a stirred solution of compound 1a
(1.00 g, 2.20 mmol) in dry toluene (100 mL). The mixture was re-
fluxed for 2 h., and triethylaminehydrochloride was filtered off.
Toluene was evaporated and the crude product was purified by col-
umn chromatography with THF/Toluene (1:3), yield; 1.37 g (87%).
2.2.12. 6,6-Dichloro-4,4-di(morpholino)-3-phenyl–3,4-dihydro-
spiro[1,3,2-benzoxazaphosphorine][2k5,4k5,6k5]
[1,3,5,2,4,6]triazatriphosphorine (2d)
The workup procedure was similar to that of compound 1d,
using morpholine (0.38 mL, 4.36 mmol) and 2a (1.18 g,
2.50 mmol). Rf = 0.54 (THF/Toluene; 1:3). Yield; 0.25 g (19%) and
mp: 178 °C. Anal. Calc. for C21H27N6P3O3Cl2; C, 43.83; H, 4.73; N,
14.61. Found: C, 44.02; H, 4.72; N, 15.30%., m/z: 574 (575
2.2.8. 4,4,6,6-Tetrachloro-3-phenyl-3,4-dihydrospiro[1,3,2-
benzoxazaphosphorine][2k5,4k5,6k5] [1,3,5,2,4,6]triazatriphosphorine
(2a)
The workup procedure was similar to that of compound 1a,
using 2 (1.15 g, 5.75 mmol) and N3P3Cl6 (2.00 g, 5.75 mmol). (Tol-
uene, Rf = 0.68). Yield; 0.65 g (24%) and mp: 118 °C. Anal. Calc. for
C13H11N4 P3OCl4; C, 32.92; H, 2.34; N, 11.82. Found: C, 32.56; H,
[M + H]+). FTIR (KBr, cmꢀ1):
m 3090;3074 (C–H arom.), 2946;2860
(C–H aliph.), 1199;1172 (P@N), 566;485 (P–Cl). 1H NMR:
(500 MHz, CDCl3, ppm): d 2.60–3.19 (m, 8H, NCH2 morp.), 3.60
3
2.40; N, 11.60%., m/z: 472 (473 [M + H]+). FTIR (KBr, cmꢀ1):
m
and 3.74 (m, 8H, NCH2CH2 morp.), 4.70 (d, 2H, JPH = 14. Hz, H1),
3088;3045 (C–H arom.), 2976;2845 (C–H aliph.), 1260;1185
7.01–7.47 (m, 9H, Ar–H). 13C{1H} NMR: (125 MHz, CDCl3, ppm): d
3
(P@N), 578;519 (P–Cl). 1H NMR (500 MHz, CDCl3, ppm): d 4.72
43.98 and 44.72 (NCH2 morp.), 52.92 (C1), 67.14 (d, JPC = 4.9 Hz,
3
3
(d, 2H, JPH = 15.0 Hz, H1), 7.23–7.85 (9H, Ar–H), 13C{1H} NMR:
NCH2CH2 morp.), 118.91 (d, JPC = 7.3 Hz, C4), 124.44 (C9), 125.54
2
3
(125 MHz, CDCl3, ppm): d 52.46 (d, JPC = 2.5 Hz, C1), 119.10 (d,
(C11), 125.76 (d, JPC = 3.5 Hz, C2), 126.63 (C6), 127.14 (C7), 128.47
3
2
3JPC = 8.8 Hz, C4), 124.70 (d, JPC = 7.4 Hz, C2), 124.80 (d,
(C5) 129.28 C10), 143.26 (C8), 150.90 (d, JPC = 8.9 Hz, C3).
3JPC = 6.30 Hz, C9), 126.71 (C11), 127.04 (C6), 127.50 (C7), 129.52
2
(C5), 129.85 (C10), 141.31 (d, JPC = 2.5 Hz, C8), 150.25 (d,
2.2.13. 4,4,6,6-Tetramorpholino-3-phenyl-3,4-dihydro-spiro[1,3,2-
benzoxazaphosphorine][2k5,4k5,6k5] [1,3,5,2,4,6]triazatriphosphorine
(2e)
2JPC = 7.5 Hz, C3).
2.2.9. 6,6-Dichloro-4,4-di(pyrrolidino)-3-phenyl-3,4-
The workup procedure was similar to that of compound 1e,
using morpholine (1.14 mL, 12.72 mmol) and 2a (1.00 g,
2.11 mmol). Rf = 0.58 (THF/Toluene; 1:2). Yield; 1.01 g (71%) and
mp: 217 °C. Anal. Calc. for C29H43N8P3O5; C, 51.47; H, 6.40; N,
16.56. Found: C, 51.33; H, 6.34; N, 16.82%., m/z: 676 (677
dihydrospiro[1,3,2-benzoxazaphosphorine][2k5,4k5,6k5]
[1,3,5,2,4,6]triazatriphosphorine (2b)
The workup procedure was similar to that of compound 1b,
using pyrrolidine (0.58 mL, 3.50 mmol) and 2a (1.65 g, 3.50 mmol).
(Toluene, Rf = 0.34). Yield; 0.38 g (20%) and mp: 158 °C. Anal. Calc.
for C21H27N6 P3OCl2; C, 46.41; H, 5.01; N, 15.47. Found: C, 45.94; H,
[M + H]+). FTIR (KBr, cmꢀ1):
m 3093;3070 (C–H arom.), 2958;2846
(C–H aliph.), 1204;1174 (P@N). 1H NMR: (500 MHz, CDCl3, ppm):
d 2.58–3.18 (m, 16H, NCH2 morp.), 3.50 and 3.67 (m, 16H,
4.76; N, 15.61%., m/z: 542 (543 [M + H]+). FTIR (KBr, cmꢀ1):
m
3
3081;3019 (C–H arom.), 2974;2869 (C–H aliph.), 1243;1172
(P@N), 576;517 (P–Cl). 1H NMR: (500 MHz, CDCl3, ppm): d 1.61
and 1.88 (m, 8H, NCH2CH2 pyrr.). 3.14 and 3.22 (m, 8H, NCH2
NCH2CH2 morp.), 4.68 (d, 2H, JPH = 14.0 Hz, H1), 6.96–7.48 (m,
9H, Ar–H). 13C{1H} NMR: (125 MHz, CDCl3, ppm): d 43.88 and
3
44.15 (NCH2 morp.), 51.78 (C1), 66.67 (d, JPC = 4.7 Hz, NCH2CH2
3
3
pyrr.), 4.83 (d, 2H, JPH = 14.6 Hz, H1), 7.10–7.48 (m, 9H, Ar–H).
morp.), 117.82 (d, JPC = 7.1 Hz, C4), 122.72 (C9), 124.68 (C11),
13C{1H} NMR: (125 MHz, CDCl3, ppm): d 24.19 and 24.37 (d,
125.12 (d, JPC = 3.4 Hz, C2), 125.37 (C6), 125.94 (C7), 128.10 (C5)
3
3JPC = 9.4 Hz, NCH2CH2 pyrr.), 43.66 and 44.11 (d, JPC = 4.4 Hz,
128.36 (C10), 143.99 (C8), 150.78 (d, JPC = 8.7 Hz, C3).
2
2
2
3
NCH2 pyrr.), 50.50 (d, JPC = 2.1 Hz, C1), 116.82 (d, JPC = 7.9 Hz,
3
C4), 121.66 (C11), 123.12 (d, JPC = 5.7 Hz, C2), 124.13 (d,
2.2.14. Microwave-assisted synthesis of compound 2e
Morpholine (1.14 mL, 12.72 mmol) and triethylamine (10.0 mL)
were added to a stirred solution of compound 2a (1.00 g,
3JPC = 3.6 Hz, C9), 124.80 (C7), 126.79 (C5), 127.13 (C10), 141.43
2
(C8), 148.98 (d, JPC = 8.5 Hz, C3).